Reassessment of the relationship between M-protein decrement and survival in multiple myeloma
Open Access
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 59 (1) , 110-112
- https://doi.org/10.1038/bjc.1989.22
Abstract
The relationship between percentage M-protein decrement and survival is assessed in 134 multiple myeloma patients. The correlation did not achieve statistical significance (P = 0.069). Multivariate analysis using the Cox proportional hazards model, including a number of previously recognised prognostic factors, showed only percentage M-protein decrement, creatinine and haemoglobin to be significantly correlated with survival. However, the R'-statistic for each of these variables was low, indicating that their prognostic power is weak. We conclude that neither the percentage M-protein decrement nor the response derived from it can be used as an accurate means of assessing the efficacy of treatment in myeloma. Mature survival data alone should be used for this purpose.This publication has 5 references indexed in Scilit:
- Are the current criteria for response useful in the management of multiple myeloma?Journal of Clinical Oncology, 1987
- Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment.Journal of Clinical Oncology, 1986
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Combination chemotherapy for multiple myelomaCancer, 1972
- THE ROLE OF THE KIDNEY IN THE CATABOLISM OF BENCE JONES PROTEINS AND IMMUNOGLOBULIN FRAGMENTSThe Journal of Experimental Medicine, 1967